UncategorizedSomite AI lands $47m to leverage AI for ‘human regeneration and repair’ Empower Meds / November 22, 2025
Uncategorized4 retreats and programmes altering the way we look at longevity – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedRejuvenate Biomed initiates Phase 2 trial for COPD-related muscle weakness – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedModular replacement could reframe how aging is addressed Empower Meds / November 22, 2025
UncategorizedJuvena kicks off first human trial of muscle regeneration therapy Empower Meds / November 22, 2025
UncategorizedMetformin combination therapy enters Phase 2 sarcopenia trial Empower Meds / November 22, 2025
UncategorizedFour Seasons launches global wellness initiative – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedRegeneron’s acquisition of 23andMe: A genomic power shift? Empower Meds / November 22, 2025
UncategorizedJuvenescence lands $76m led by Abu Dhabi healthcare giant M42 Empower Meds / November 22, 2025
